BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 20422034)

  • 1. Optimization of duplex stability and terminal asymmetry for shRNA design.
    Matveeva OV; Kang Y; Spiridonov AN; Saetrom P; Nemtsov VA; Ogurtsov AY; Nechipurenko YD; Shabalina SA
    PLoS One; 2010 Apr; 5(4):e10180. PubMed ID: 20422034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of target secondary structure on RNAi efficiency.
    Shao Y; Chan CY; Maliyekkel A; Lawrence CE; Roninson IB; Ding Y
    RNA; 2007 Oct; 13(10):1631-40. PubMed ID: 17684233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Energy profile and secondary structure impact shRNA efficacy.
    Zhou H; Zeng X
    BMC Genomics; 2009 Jul; 10 Suppl 1(Suppl 1):S9. PubMed ID: 19594886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RNAi Codex: a portal/database for short-hairpin RNA (shRNA) gene-silencing constructs.
    Olson A; Sheth N; Lee JS; Hannon G; Sachidanandam R
    Nucleic Acids Res; 2006 Jan; 34(Database issue):D153-7. PubMed ID: 16381835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A quick and efficient approach for gene silencing by using triple putative microRNA-based short hairpin RNAs.
    Shan ZX; Lin QX; Yang M; Deng CY; Kuang SJ; Zhou ZL; Xiao DZ; Liu XY; Lin SG; Yu XY
    Mol Cell Biochem; 2009 Mar; 323(1-2):81-9. PubMed ID: 19037714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Terminal Duplex Stability and Nucleotide Identity Differentially Control siRNA Loading and Activity in RNA Interference.
    Angart PA; Carlson RJ; Adu-Berchie K; Walton SP
    Nucleic Acid Ther; 2016 Oct; 26(5):309-317. PubMed ID: 27399870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved siRNA/shRNA functionality by mismatched duplex.
    Wu H; Ma H; Ye C; Ramirez D; Chen S; Montoya J; Shankar P; Wang XA; Manjunath N
    PLoS One; 2011; 6(12):e28580. PubMed ID: 22174840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved asymmetry prediction for short interfering RNAs.
    Malefyt AP; Wu M; Vocelle DB; Kappes SJ; Lindeman SD; Chan C; Walton SP
    FEBS J; 2014 Jan; 281(1):320-30. PubMed ID: 24393396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Criteria for effective design, construction, and gene knockdown by shRNA vectors.
    Taxman DJ; Livingstone LR; Zhang J; Conti BJ; Iocca HA; Williams KL; Lich JD; Ting JP; Reed W
    BMC Biotechnol; 2006 Jan; 6():7. PubMed ID: 16433925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and validation of siRNAs and shRNAs.
    Tilesi F; Fradiani P; Socci V; Willems D; Ascenzioni F
    Curr Opin Mol Ther; 2009 Apr; 11(2):156-64. PubMed ID: 19330721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimized models for design of efficient miR30-based shRNAs.
    Matveeva OV; Nazipova NN; Ogurtsov AY; Shabalina SA
    Front Genet; 2012; 3():163. PubMed ID: 22952469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. shRNA expression constructs designed directly from siRNA oligonucleotide sequences.
    Barøy T; Sørensen K; Lindeberg MM; Frengen E
    Mol Biotechnol; 2010 Jun; 45(2):116-20. PubMed ID: 20119685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thermodynamic instability of siRNA duplex is a prerequisite for dependable prediction of siRNA activities.
    Ichihara M; Murakumo Y; Masuda A; Matsuura T; Asai N; Jijiwa M; Ishida M; Shinmi J; Yatsuya H; Qiao S; Takahashi M; Ohno K
    Nucleic Acids Res; 2007; 35(18):e123. PubMed ID: 17884914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design of nuclease-resistant fork-like small interfering RNA (fsiRNA).
    Chernolovskaya EL; Zenkova MA
    Methods Mol Biol; 2013; 942():153-68. PubMed ID: 23027050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Construction of simple and efficient DNA vector-based short hairpin RNA expression systems for specific gene silencing in mammalian cells.
    Cheng TL; Chang WT
    Methods Mol Biol; 2007; 408():223-41. PubMed ID: 18314586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. siDirect 2.0: updated software for designing functional siRNA with reduced seed-dependent off-target effect.
    Naito Y; Yoshimura J; Morishita S; Ui-Tei K
    BMC Bioinformatics; 2009 Nov; 10():392. PubMed ID: 19948054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Re-Engineering RNA Molecules into Therapeutic Agents.
    Egli M; Manoharan M
    Acc Chem Res; 2019 Apr; 52(4):1036-1047. PubMed ID: 30912917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crystal structure, stability and in vitro RNAi activity of oligoribonucleotides containing the ribo-difluorotoluyl nucleotide: insights into substrate requirements by the human RISC Ago2 enzyme.
    Li F; Pallan PS; Maier MA; Rajeev KG; Mathieu SL; Kreutz C; Fan Y; Sanghvi J; Micura R; Rozners E; Manoharan M; Egli M
    Nucleic Acids Res; 2007; 35(19):6424-38. PubMed ID: 17881374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An RNAi in silico approach to find an optimal shRNA cocktail against HIV-1.
    Méndez-Ortega MC; Restrepo S; Rodríguez-R LM; Pérez I; Mendoza JC; Martínez AP; Sierra R; Rey-Benito GJ
    Virol J; 2010 Dec; 7():369. PubMed ID: 21172023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fundamental differences in the equilibrium considerations for siRNA and antisense oligodeoxynucleotide design.
    Lu ZJ; Mathews DH
    Nucleic Acids Res; 2008 Jun; 36(11):3738-45. PubMed ID: 18483081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.